Evidence map›Paper›PMID 28794185›Full record

ArticleGenes & development2017

Id genes are essential for early heart formation.

Thomas J Cunningham, Michael S Yu, Wesley L McKeithan, Sean Spiering, Florent Carrette, Chun-Teng Huang, Paul J Bushway, Matthew Tierney, Sonia Albini, Mauro Giacca and 9 more

Abstract read
In one paragraph

Article in Genes & development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Deciphering the Cardiovascular Potential of Human CD34International journal of molecular sciences · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Single-cell RNA sequencing reveals thatThe European respiratory journal · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Thomas J CunninghamSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Michael S YuSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Wesley L McKeithanSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Sean SpieringSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Florent CarretteSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Chun-Teng HuangSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Paul J BushwayDepartment of Bioengineering, University of California at San Diego, La Jolla, California 92037, USA.
Matthew TierneySanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Sonia AlbiniSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Mauro GiaccaInternational Centre for Genetic Engineering and Biotechnology, 34149 Trieste, Italy.
Miguel ManoCenter for Neuroscience and Cell Biology (CNC), University of Coimbra, 3004-504 Coimbra, Portugal.
Pier Lorenzo PuriSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Alessandra SaccoSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Pilar Ruiz-LozanoSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Jean-Francois RiouUMR 7622 Developmental Biology, Sorbonne Universités, University Pierre and Marie Curie, F- 75005 Paris, France.
Muriel UmbhauerUMR 7622 Developmental Biology, Sorbonne Universités, University Pierre and Marie Curie, F- 75005 Paris, France.
Gregg DuesterSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Mark MercolaSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.
Alexandre R ColasSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, 92037, USA.

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Pathogenic Alterations of the 3D Epigenetic Landscape in Dystrophin-Deficient Skeletal Muscles and Reversal by Dystrophin Re-ExpressionR01AR056712 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Pier Lorenzo Puri · 2009 to 2026
$7.3M
MicroRNA Control of Dilated CardiomyopathyR01HL130840 · NHLBI · STANFORD UNIVERSITY · PI MARK MERCOLA, Shankar Subramaniam · 2016 to 2026
$4.6M
Signal-dependent switch of SWI/SNF by miRNAs & control of muscle stem cell fateR01AR052779 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PURI, PIER LORENZO · 2006 to 2015
$4.1M
Integrative Bioengineering of Heart, Vessels, and BloodT32HL105373 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, INTAGLIETTA, MARCOS · 2010 to 2019
$3.6M
Role of miR25 in Heart FailureR01HL128072 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAJJAR, ROGER J., MERCOLA, MARK · 2015 to 2018
$2.5M
microRNAs and Integrative Control on Cardiopoiesis - CHANGE OF GRANTEE INSTITUTIOR01HL113601 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MERCOLA, MARK · 2012 to 2016
$2.2M
Factors Regulating Development of Appendicular Skeletal ProgenitorsR01AR067731 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI DUESTER, GREGG L · 2015 to 2019
$2.1M
Role of STAT3 in muscle stem cell activationR01AR064873 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SACCO, ALESSANDRA · 2014 to 2018
$2.1M
Stem cell toxicology assays for cardiac differentiationR44ES023521 · NIEHS · VALA SCIENCES, INC. · PI MCDONOUGH, PATRICK M · 2016 to 2017
$1.5M
Reconstruction & Modeling of Networks Involved in Cardiomyocyte DifferentiationR33HL088266 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MERCOLA, MARK · 2007 to 2009
$1.0M
Role of proteoglycan sulfation during muscle regeneration in dystrophic animalsF31AR065923 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI TIERNEY, MATTHEW · 2014 to 2016
$63k
NCI NIH HHS P30 CA030199NHLBI NIH HHS R01 HL113601NHLBI NIH HHS R01 HL128072NHLBI NIH HHS R01 HL130840NHLBI NIH HHS R33 HL088266NIAMS NIH HHS F31 AR065923NIAMS NIH HHS R01 AR052779NIAMS NIH HHS R01 AR056712NIAMS NIH HHS R01 AR064873NIAMS NIH HHS R01 AR067731NIEHS NIH HHS R44 ES023521
6 · The paper itself

Abstract

Deciphering the fundamental mechanisms controlling cardiac specification is critical for our understanding of how heart formation is initiated during embryonic development and for applying stem cell biology to regenerative medicine and disease modeling. Using systematic and unbiased functional screening approaches, we discovered that the Id family of helix-loop-helix proteins is both necessary and sufficient to direct cardiac mesoderm formation in frog embryos and human embryonic stem cells. Mechanistically, Id proteins specify cardiac cell fate by repressing two inhibitors of cardiogenic mesoderm formation-Tcf3 and Foxa2-and activating inducers Evx1, Grrp1, and Mesp1. Most importantly, CRISPR/Cas9-mediated ablation of the entire Id (Id1-4) family in mouse embryos leads to failure of anterior cardiac progenitor specification and the development of heartless embryos. Thus, Id proteins play a central and evolutionarily conserved role during heart formation and provide a novel means to efficiently produce cardiovascular progenitors for regenerative medicine and drug discovery applications.

Indexed as

AnimalsBasic Helix-Loop-Helix ProteinsCell DifferentiationCell LineCell LineageEmbryo, MammalianEmbryonic Stem CellsEmbryo, NonmammalianGene EditingGene Expression Regulation, DevelopmentalHeartHeart Defects, CongenitalHumansInhibitor of Differentiation ProteinsMesodermMiceBasic Helix-Loop-Helix ProteinsInhibitor of Differentiation Proteinscardiac mesoderm specificationcardiac progenitorsCRISPR/Cas9-mediated quadruple knockoutheartlessId proteinsplatform for cardiac disease modeling and drug discovery

Identifiers

PMID28794185
PMCPMC5580654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.